COVID-19: integrating the complexity of systemic and pulmonary immunopathology to identify biomarkers for different outcomes (2021)
- Authors:
- USP affiliated authors: SORGI, CARLOS ARTERIO - FFCLRP ; RUSSO, ELISA MARIA DE SOUSA - FCFRP ; FERNANDES, ANA PAULA MORAIS - EERP ; CARDOSO, CRISTINA RIBEIRO DE BARROS - FCFRP ; FACCIOLI, LUCIA HELENA - FCFRP ; BARUFFI, MARCELO DIAS - FCFRP ; BONATO, VANIA LUIZA DEPERON - FMRP ; SILVA, THAIS FERNANDA DE CAMPOS FRAGA DA - FMRP
- Unidades: FFCLRP; FCFRP; EERP; FMRP
- DOI: 10.3389/fimmu.2020.599736
- Subjects: CORONAVIRUS; SISTEMA IMUNE; INFLAMAÇÃO; PULMÃO; IMUNOPATOLOGIA
- Keywords: Coronavirus disease 2019; Peripheral immune response; Pulmonary inflammation; Lung immunopathology; Damage tolerance
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Immunology
- ISSN: 1664-3224
- Volume/Número/Paginação/Ano: v. 11, art. 599736, 2021
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
FRAGA-SILVA, Thais Fernanda de Campos et al. COVID-19: integrating the complexity of systemic and pulmonary immunopathology to identify biomarkers for different outcomes. Frontiers in Immunology, v. 11, 2021Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2020.599736. Acesso em: 22 jan. 2026. -
APA
Fraga-Silva, T. F. de C., Maruyama, S. R., Sorgi, C. A., Russo, E. M. de S., Fernandes, A. P. M., Cardoso, C. R. de B., et al. (2021). COVID-19: integrating the complexity of systemic and pulmonary immunopathology to identify biomarkers for different outcomes. Frontiers in Immunology, 11. doi:10.3389/fimmu.2020.599736 -
NLM
Fraga-Silva TF de C, Maruyama SR, Sorgi CA, Russo EM de S, Fernandes APM, Cardoso CR de B, Faccioli LH, Dias-Baruffi M, Bonato VLD. COVID-19: integrating the complexity of systemic and pulmonary immunopathology to identify biomarkers for different outcomes [Internet]. Frontiers in Immunology. 2021 ; 11[citado 2026 jan. 22 ] Available from: https://doi.org/10.3389/fimmu.2020.599736 -
Vancouver
Fraga-Silva TF de C, Maruyama SR, Sorgi CA, Russo EM de S, Fernandes APM, Cardoso CR de B, Faccioli LH, Dias-Baruffi M, Bonato VLD. COVID-19: integrating the complexity of systemic and pulmonary immunopathology to identify biomarkers for different outcomes [Internet]. Frontiers in Immunology. 2021 ; 11[citado 2026 jan. 22 ] Available from: https://doi.org/10.3389/fimmu.2020.599736 - Production of lipid bodies, cytokines and leukotrienes in alveolar macrophages, by galectin-1 induction
- The inhibition of 5-Lipoxygenase (5-LO) products leukotriene B4 (LTB 4 ) and cysteinyl leukotrienes (cysLTs) modulates the inflammatory response and improves cutaneous wound healing
- Leukotrienes in the susceptibility and resistence to infection by Histoplasma capsulatum
- Role of 5-lipoxigenase on lipid body formation induced by Histoplasma capsulatum cell wall 'beta'-glucan and coinfected immunity
- Papel do TLR2 na histoplasmose experimental
- A histoplasmose na mira da ciência
- Comparison of Lafoensia pacari anti-inflammatory activity with dexamethasone in toxocariasis
- Prostaglandins in immune cell response in the histoplasmosis
- Biodegradable microspheres containing leukotriene 'B IND.4' and cell-free antigens from Histoplasma capsulatum activate murine bone marrow-derived macrophages
- Effect of leukotrienes on infection with Paracoccidioides brasiliensis in mice strains genetically selected for acute inflammatory response
Informações sobre o DOI: 10.3389/fimmu.2020.599736 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003075891.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
